T he uptick in the usage of GLP-1 drugs for weight loss, including Mounjaro, Zepbound and Ozempic, has begun careening smack ...

As the use of GLP-1s soars in popularity, diners are wrestling with new restaurant etiquette dilemmas — and adjusting ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The surging popularity of hunger-suppressing weight-loss jabs, like Ozempic and Mounjaro, is having a slimming effect on ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...